Standardized Incidence Ratio and Standardized Mortality Ratio of Malignant Mesothelioma in a Worker Cohort Using Employment Insurance Database in Korea
Abstract
:1. Introduction
2. Materials and Methods
3. Results
3.1. General Characteristics of the Subjects
3.2. SMR, SIR by Major Division of the KSIC
3.3. SIR, SMR from Subdivisions of the Manufacturing Industry
3.4. SIR and SMR of Non-Manufacturing Industry
4. Discussion
5. Conclusions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Rushton, L. The Global Burden of Occupational Disease. Curr. Environ. Health Rep. 2017, 4, 340–348. [Google Scholar] [CrossRef] [Green Version]
- Ruffie, P.A. Pleural Mesothelioma. Curr. Opin. Oncol. 1991, 3, 328–334. [Google Scholar] [CrossRef]
- Muscat, J.E.; Wynder, E.L. Cigarette Smoking, Asbestos Exposure, and Malignant Mesothelioma. Cancer Res. 1991, 51, 2263–2267. [Google Scholar] [PubMed]
- Choi, J.K.; Paek, D.M.; Paik, N.W. The Production, the Use, the Number of Workers and Exposure Level of Asbestos in Korea. Korean Ind. Hyg. Assoc. J. 1998, 8, 242–253. [Google Scholar]
- Kim, H.R. Overview of Asbestos Issues in Korea. J. Korean Med. Sci. 2009, 24, 363–367. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- KOSIS. KOSIS Statistics Portal. Available online: https://kosis.kr/index/index.do (accessed on 21 July 2021).
- Kwak, K.M.; Paek, D.; Hwang, S.-S.; Ju, Y.-S. Estimated future incidence of malignant mesothelioma in South Korea: Projection from 2014 to 2033. PLoS ONE 2017, 12, e0183404. [Google Scholar] [CrossRef] [Green Version]
- Lee, E.-S.; Kim, Y.-K. Asbestos Exposure Level and the Carcinogenic Risk Due to Corrugated Asbestos-Cement Slate Roofs in Korea. Int. J. Environ. Res. Public Health 2021, 18, 6925. [Google Scholar] [CrossRef]
- Lee, S.; Kang, D.; Kim, Y.; Kim, Y.-J.; Kim, S.-Y. Activity-Based Exposure Levels and Cancer Risk Assessment Due to Naturally Occurring Asbestos for the Residents Near Abandoned Asbestos Mines in South Korea. Int. J. Environ. Res. Public Health 2021, 18, 5225. [Google Scholar] [CrossRef] [PubMed]
- Kwak, K.; Zoh, K.; Paek, D. Incidence of Cancer and Asbestos-Related Diseases among Residents Living near Abandoned Asbestos Mines in South Korea: A Retrospective Cohort Study Using National Health Insurance Database. Int. J. Environ. Res. Public Health 2021, 18, 875. [Google Scholar] [CrossRef] [PubMed]
- An, Y.S.; Kim, H.D.; Kim, H.C.; Jeong, K.S.; Ahn, Y.S. The characteristics of asbestos-related disease claims made to the Korea Workers’ Compensation and Welfare Service (KCOMWEL) from 2011 to 2015. Ann. Occup. Environ. Med. 2018, 30, 45. [Google Scholar] [CrossRef] [PubMed]
- Onyije, F.; Hosseini, B.; Togawa, K.; Schüz, J.; Olsson, A. Cancer Incidence and Mortality among Petroleum Industry Workers and Residents Living in Oil Producing Communities: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health 2021, 18, 4343. [Google Scholar] [CrossRef] [PubMed]
- Ierardi, A.M.; Urban, A.; Marsh, G.M. A quantitative weight of evidence assessment of Hill’s guidelines for causal inference for cosmetic talc as a cause of mesothelioma. Toxicol. Appl. Pharmacol. 2021, 417, 115461. [Google Scholar] [CrossRef] [PubMed]
- DeBono, N.L.; Warden, H.; Mph, C.L.; Shakik, S.; Dakouo, M.; MacLeod, J.; Demers, P.A. Incidence of mesothelioma and asbestosis by occupation in a diverse workforce. Am. J. Ind. Med. 2021, 64, 476–487. [Google Scholar] [CrossRef] [PubMed]
- Agudo, A.; Escolar, A.; González, C.A.; Bleda, M.J.; Ramírez, J.; Hernández, M.J.B.; López, F.; Calleja, A.; Panadès, R.; Turuguet, D.; et al. Occupation and risk of malignant pleural mesothelioma: A case-control study in Spain. Am. J. Ind. Med. 2000, 37, 159–168. [Google Scholar] [CrossRef]
- Rolland, P.; Gramond, C.; Lacourt, A.; Astoul, P.; Chamming’S, S.; Ducamp, S.; Frenay, C.; Salle, F.G.; Ilg, A.G.S.; Imbernon, E.; et al. Occupations and industries in France at high risk for pleural mesothelioma: A population-based case-control study (1998–2002). Am. J. Ind. Med. 2010, 53, 1207–1219. [Google Scholar] [CrossRef] [PubMed]
- Burdorf, A.; Dahhan, M.; Swuste, P. Occupational characteristics of cases with asbestos-related diseases in The Netherlands. Ann. Occup. Hyg. 2003, 47, 485–492. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tagnon, I.; Blot, W.J.; Stroube, R.B.; Day, N.; Morris, L.E.; Peace, B.B.; Fraumeni, J.F. Mesothelioma associated with the shipbuilding industry in coastal Virginia. Cancer Res. 1980, 40, 3875–3879. [Google Scholar] [PubMed]
- Bianchi, C.; Brollo, A.; Ramani, L.; Bianchi, T.; Giarelli, L. Asbestos Exposure in Malignant Mesothelioma of the Pleura: A Survey of 557 Cases. Ind. Health 2001, 39, 161–167. [Google Scholar] [CrossRef] [PubMed]
- Jung, S.-H.; Kim, H.-R.; Koh, S.-B.; Yong, S.-J.; Chung, M.J.; Lee, C.-H.; Han, J.; Eom, M.-S.; Oh, S.-S. A decade of malignant mesothelioma surveillance in Korea. Am. J. Ind. Med. 2012, 55, 869–875. [Google Scholar] [CrossRef] [PubMed]
- Lee, H.-E.; Kim, H.R. Occupational Respiratory Cancer in Korea. J. Korean Med. Sci. 2010, 25, S94–S98. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Huh, D.-A.; Kang, M.-S.; Lee, J.; Choi, J.Y.; Moon, K.W.; Lee, Y.-J. Occupational and environmental asbestos exposure and the risk of lung cancer in Korea: A case-control study in South Chungcheong Province of Korea. PLoS ONE 2021, 16, e0249790. [Google Scholar] [CrossRef]
- Kang, D.; Jung, S.; Kim, Y.-J.; Kim, J.; Choi, S.; Kim, S.Y.; Kim, Y. Reconstruction of the Korean Asbestos Job Exposure Matrix. Saf. Health Work. 2021, 12, 74–95. [Google Scholar] [CrossRef] [PubMed]
- MDIS. MDIS—Microdata Integrated Service. Available online: https://mdis.kostat.go.kr/index.do (accessed on 21 July 2021).
- Gemba, K.; Fujimoto, N.; Kato, K.; Aoe, K.; Takeshima, Y.; Inai, K.; Kishimoto, T. National survey of malignant mesothelioma and asbestos exposure in Japan. Cancer Sci. 2012, 103, 483–490. [Google Scholar] [CrossRef]
- Roelofs, C.R.; Ms, G.J.K.; Davis, L.K.; Clapp, R.W.; Hunt, P.R. Mesothelioma and employment in massachusetts: Analysis of cancer registry data 1988–2003. Am. J. Ind. Med. 2013, 56, 985–992. [Google Scholar] [CrossRef] [PubMed]
- Mazurek, J.M.; Syamlal, G.; Wood, J.M.; Hendricks, S.A.; Weston, A. Malignant Mesothelioma Mortality—United States, 1999–2015. MMWR Morb. Mortal. Wkly. Rep. 2017, 66, 214–218. [Google Scholar] [CrossRef] [PubMed]
- Goldberg, M.; Imbernon, E.; Rolland, P.; Ilg, A.G.S.; Savès, M.; De Quillacq, A.; Frenay, C.; Chamming’S, S.; Arveux, P.; Boutin, C.; et al. The French National Mesothelioma Surveillance Program. Occup. Environ. Med. 2006, 63, 390–395. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Van Oyen, S.C.; Peters, S.; Alfonso, H.; Fritschi, L.; de Klerk, N.; Reid, A.; Franklin, P.; Gordon, L.; Benke, G.; Musk, A.W. Development of a Job-Exposure Matrix (AsbJEM) to Estimate Occupational Exposure to Asbestos in Australia. Ann. Occup. Hyg. 2015, 59, 737–748. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fazzo, L.; Minelli, G.; De Santis, M.; Bruno, C.; Zona, A.; Conti, S.; Comba, P. Epidemiological surveillance of mesothelioma mortality in Italy. Cancer Epidemiol. 2018, 55, 184–191. [Google Scholar] [CrossRef]
- Paci, E.; Dini, S.; Buiatti, E.; Costantini, A.S.; Lenzi, S.; Zappa, M. Malignant mesothelioma in non-asbestos textile workers in florence. Am. J. Ind. Med. 1987, 11, 249–254. [Google Scholar] [CrossRef] [PubMed]
- Chiappino, G.; Mensi, C.; Riboldi, L.; Rivolta, G. Asbestos risk in the textile industry: Final confirmation of data from the Lombardy Mesothelioma Registry. La Med. Del Lav. 2003, 94, 521–530. [Google Scholar]
- Craighead, J.E.; Gibbs, A.R. Asbestos and Its Diseases; Oxford University Press: New York, NY, USA, 2008; ISBN 978-0-19-517869-2. [Google Scholar]
- Marinaccio, A.; Corfiati, M.; Binazzi, A.; Di Marzio, D.; Scarselli, A.; Ferrante, P.; Bonafede, M.; Verardo, M.; Mirabelli, D.; Gennaro, V.; et al. The epidemiology of malignant mesothelioma in women: Gender differences and modalities of asbestos exposure. Occup. Environ. Med. 2018, 75, 254–262. [Google Scholar] [CrossRef] [PubMed]
- Choi, S.; Kang, D.; Park, D.; Lee, H.; Choi, B. Developing Asbestos Job Exposure Matrix Using Occupation and Industry Specific Exposure Data (1984–2008) in Republic of Korea. Saf. Health Work 2017, 8, 105–115. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kim, S.-Y.; Kim, Y.-C.; Kim, Y.; Hong, W.-H. Predicting the mortality from asbestos-related diseases based on the amount of asbestos used and the effects of slate buildings in Korea. Sci. Total Environ. 2016, 542, 1–11. [Google Scholar] [CrossRef] [PubMed]
- Kang, D.-M.; Kim, J.-E.; Kim, Y.-K.; Lee, H.-H.; Kim, S.-Y. Occupational Burden of Asbestos-Related Diseases in Korea, 1998–2013: Asbestosis, Mesothelioma, Lung Cancer, Laryngeal Cancer, and Ovarian Cancer. J. Korean Med. Sci. 2018, 33, e226. [Google Scholar] [CrossRef] [PubMed]
- Kim, K. Policy Review in Reform of Employment Safety Nets. Res. Labour Policy 2020, 20, 123–153. [Google Scholar]
Men (%) | Women (%) | Total (%) | ||||
---|---|---|---|---|---|---|
Gender | 13,285,895 | (56.0) | 10,452,705 | (44.0) | 23,738,600 | (100.0) |
Age at enrollment | ||||||
<20 yrs | 463,532 | (3.5) | 505,326 | (4.8) | 968,858 | (4.1) |
20–50 yrs | 10,004,635 | (75.3) | 7,860,565 | (75.2) | 17,865,200 | (75.3) |
≥50 yrs | 2,817,728 | (21.2) | 2,086,814 | (20.0) | 4,904,542 | (20.7) |
Hiring year | ||||||
~2000 | 2,143,106 | (16.1) | 1,056,479 | (10.1) | 3,199,585 | (13.5) |
2001–2010 | 3,896,322 | (29.3) | 2,985,047 | (28.6) | 6,881,369 | (29.0) |
2011~ | 7,246,467 | (54.5) | 6,411,179 | (61.3) | 13,657,646 | (57.5) |
Average year of follow-up | 8 | 7 | ||||
Person-Years | 107,138,561 | 72,794,387 | 179,932,948 | |||
Total death cases | 448,843 | 85,986 | 534,829 | |||
SMR of all cause death (95% CI) | 1.28 (1.28–1.29) | 0.95 (0.94–0.95) | ||||
Mesothelioma | ||||||
Incidence | 480 | 141 | 621 | |||
death | 216 | 54 | 270 | |||
Longest working Industry | ||||||
A | 168,355 | (1.3) | 68,750 | (0.7) | 237,105 | (1.0) |
B | 54,097 | (0.4) | 7284 | (0.1) | 61,381 | (0.3) |
C | 6,201,849 | (46.7) | 3,481,366 | (33.3) | 9,683,215 | (40.8) |
D | 78,711 | (0.6) | 21,919 | (0.2) | 100,630 | (0.4) |
E | 113,468 | (0.9) | 42,696 | (0.4) | 156,164 | (0.7) |
F | 1,238,798 | (9.3) | 370,243 | (3.5) | 1,609,041 | (6.8) |
G | 1,385,506 | (10.4) | 1,518,780 | (14.5) | 2,904,286 | (12.2) |
H | 812,042 | (6.1) | 192,496 | (1.8) | 1,004,538 | (4.2) |
I | 456,363 | (3.4) | 810,898 | (7.8) | 1,267,261 | (5.3) |
J | 459,524 | (3.5) | 397,696 | (3.8) | 857,220 | (3.6) |
K | 350,804 | (2.6) | 346,045 | (3.3) | 696,849 | (2.9) |
L | 331,072 | (2.5) | 187,645 | (1.8) | 518,717 | (2.2) |
M | 350,892 | (2.6) | 329,055 | (3.1) | 679,947 | (2.9) |
N | 526,081 | (4.0) | 660,627 | (6.3) | 1,186,708 | (5.0) |
O | 198,361 | (1.5) | 311,355 | (3.0) | 509,716 | (2.1) |
P | 162,302 | (1.2) | 469,446 | (4.5) | 631,748 | (2.7) |
Q | 201,004 | (1.5) | 1,032,659 | (9.9) | 1,233,663 | (5.2) |
R | 62,673 | (0.5) | 62,860 | (0.6) | 125,533 | (0.5) |
S | 124,080 | (0.9) | 136,157 | (1.3) | 260,237 | (1.1) |
T | 156 | (0.0) | 965 | (0.0) | 1121 | (0.0) |
U | 9555 | (0.1) | 3734 | (0.0) | 13,289 | (0.1) |
Asbestos Exposure | ||||||
Asbestos-JEM | 1,102,008 | (8.3) | 1,311,577 | (12.5) | 2,413,585 | (10.2) |
Industries of asbestos-JEM | 5,260,955 | (39.6) | 4,142,037 | (39.6) | 9,402,992 | (39.6) |
KSIC | Men | Women | Men | Women | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
OBS | SIR | 95% CI | OBS | SIR | 95% CI | OBS | SMR | 95% CI | OBS | SMR | 95% CI | |
Total | 480 | 1.36 | (1.24–1.48) * | 141 | 1.44 | (1.23–1.7) * | 216 | 0.88 | (0.77–1.01) | 54 | 0.95 | (0.73–1.24) |
A | 9 | 1.51 | (0.69–2.86) | 2 | 2.06 | (0.25–7.45) | 7 | 1.63 | (0.66–3.37) | 1 | 1.56 | (0.04–8.69) |
B | 2 | 0.80 | (0.1–2.91) | . | . | 1 | 0.57 | (0.01–3.2) | . | . | ||
C | 183 | 1.54 | (1.33–1.78) * | 57 | 1.62 | (1.25–2.11) * | 81 | 1.02 | (0.82–1.27) | 26 | 1.30 | (0.89–1.91) |
D | 5 | 2.02 | (0.66–4.71) | . | . | 1 | 0.62 | (0.02–3.43) | . | . | ||
E | 6 | 1.25 | (0.46–2.72) | . | . | 2 | 0.59 | (0.07–2.12) | . | . | ||
F | 76 | 1.72 | (1.37–2.15) * | 12 | 3.31 | (1.71–5.79) * | 43 | 1.40 | (1.04–1.89) * | 5 | 2.36 | (0.77–5.51) |
G | 28 | 1.24 | (0.85–1.79) | 12 | 1.34 | (0.69–2.35) | 14 | 0.92 | (0.5–1.54) | 3 | 0.63 | (0.13–1.84) |
H | 48 | 1.26 | (0.95–1.67) | 1 | 0.56 | (0.01–3.12) | 21 | 0.80 | (0.52–1.23) | 1 | 1.00 | (0.03–5.56) |
I | 11 | 2.56 | (1.28–4.58) * | 10 | 1.35 | (0.65–2.48) | 6 | 2.07 | (0.76–4.51) | 4 | 0.91 | (0.25–2.33) |
J | 14 | 1.70 | (0.93–2.85) | 4 | 1.84 | (0.5–4.71) | 7 | 1.29 | (0.52–2.65) | 2 | 1.86 | (0.23–6.71) |
K | 6 | 0.49 | (0.18–1.06) | 4 | 1.48 | (0.4–3.8) | 1 | 0.12 | (0–0.69) | 2 | 1.5 | (0.18–5.4) |
L | 39 | 1.34 | (0.98–1.83) | 7 | 1.95 | (0.78–4.02) | 13 | 0.60 | (0.32–1.03) | 3 | 1.26 | (0.26–3.68) |
M | 11 | 1.23 | (0.61–2.19) | 1 | 0.49 | (0.01–2.75) | 3 | 0.48 | (0.1–1.41) | . | . | |
N | 22 | 0.82 | (0.54–1.25) | 11 | 1.02 | (0.51–1.82) | 7 | 0.35 | (0.14–0.72) | 3 | 0.43 | (0.09–1.24) |
O | 9 | 1.02 | (0.47–1.94) | 3 | 0.67 | (0.14–1.95) | 5 | 0.74 | (0.24–1.73) | 1 | 0.32 | (0.01–1.81) |
P | 2 | 0.52 | (0.06–1.87) | 7 | 2.19 | (0.88–4.51) | . | . | 1 | 0.59 | (0.01–3.27) | |
Q | 3 | 0.58 | (0.12–1.69) | 7 | 0.92 | (0.37–1.9) | 2 | 0.55 | (0.07–1.98) | 2 | 0.45 | (0.05–1.64) |
R | 1 | 0.66 | (0.02–3.69) | 1 | 1.74 | (0.04–9.67) | . | . | . | . | ||
S | 3 | 0.67 | (0.14–1.95) | 1 | 0.66 | (0.02–3.67) | 1 | 0.32 | (0.01–1.77) | . | . | |
T | . | . | 1 | 31.4 | (0.8–174.97) | . | . | . | . | |||
U | 2 | 2.14 | (0.26–7.73) | . | . | 1 | 1.54 | (0.04–8.59) | . | . |
KSIC | Men | Women | Men | Women | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
OBS | SIR | 95% CI | OBS | SIR | 95% CI | OBS | SMR | 95% CI | OBS | SMR | 95% CI | |
C | 183 | 1.54 | (1.33–1.78) * | 57 | 1.62 | (1.25–2.11) * | 81 | 1.02 | (0.82–1.27) | 26 | 1.30 | (0.89–1.91) |
10 | 12 | 1.33 | (0.69–2.33) | 10 | 1.70 | (0.81–3.12) | 6 | 0.99 | (0.36–2.15) | 6 | 1.72 | (0.63–3.74) |
102 | 4 | 4.13 | (1.12–10.56) * | 1 | 0.78 | (0.02–4.33) | 2 | 3.03 | (0.37–10.94) | 0 | ||
10219 | 2 | 9.60 | (1.16–34.7) * | 0 | . | 1 | 7.01 | (0.18–39.04) | 0 | |||
103 | 0 | 3 | 3.97 | (0.82–11.59) | 0 | 3 | 6.31 | (1.3–18.45) * | ||||
106 | 0 | 2 | 13.27 | (1.61–47.94) * | 0 | 1 | 11.53 | (0.29–64.25) | ||||
10620 | 0 | . | 2 | 46.05 | (5.58–166.34) * | 0 | . | 1 | 43.03 | (1.09–239.77) * | ||
10713 | 1 | 1.46 | (0.04–8.14) | 2 | 4.51 | (0.55–16.3) | 1 | 2.23 | (0.06–12.44) | 2 | 8.32 | (1.01–30.07) * |
13 | 14 | 1.55 | (0.84–2.59) | 6 | 1.49 | (0.55–3.25) | 4 | 0.64 | (0.17–1.63) | 3 | 1.28 | (0.26–3.73) |
13211 | 3 | 8.66 | (1.79–25.3) * | 0 | . | 2 | 8.34 | (1.01–30.12) * | 0 | . | ||
139 | 4 | 3.22 | (0.88–8.25) | 3 | 4.81 | (0.99–14.07) | 1 | 1.17 | (0.03–6.53) | 1 | 2.75 | (0.07–15.33) |
13999 | 3 | 4.49 | (0.93–13.12) | 3 | 7.27 | (1.5–21.25) * | 0 | . | 1 | 4.18 | (0.11–23.28) | |
16 | 3 | 1.09 | (0.23–3.19) | 3 | 7.31 | (1.51–21.36) * | 2 | 1.05 | (0.13–3.8) | 1 | 4.11 | (0.1–22.92) |
162 | 2 | 1.16 | (0.14–4.19) | 3 | 10.63 | (2.19–31.07) * | 2 | 1.69 | (0.2–6.11) | 1 | 6.01 | (0.15–33.48) |
16232 | 0 | . | 1 | 62.05 | (1.57–345.73) * | 0 | . | 1 | 106.59 | (2.7–593.9) * | ||
17 | 6 | 1.75 | (0.64–3.8) | 4 | 5.89 | (1.6–15.08) * | 3 | 1.29 | (0.27–3.76) | 1 | 2.50 | (0.06–13.95) |
171 | 3 | 2.28 | (0.47–6.67) | 2 | 12.05 | (1.46–43.52) * | 0 | 0 | ||||
17124 | 0 | . | 2 | 102.63 | (12.43–370.74) * | 0 | . | 0 | . | |||
17222 | 0 | . | 1 | 27.83 | (0.7–155.06) | 0 | . | 1 | 47.35 | (1.2–263.79) | ||
19 | 3 | 3.96 | (0.82–11.57) | 0 | 2 | 3.95 | (0.48–14.28) | 0 | ||||
19210 | 3 | 6.37 | (1.31–18.6) * | 0 | . | 2 | 6.51 | (0.79–23.51) | 0 | . | ||
20 | 13 | 1.59 | (0.85–2.73) | 2 | 1.45 | (0.18–5.22) | 3 | 0.55 | (0.11–1.6) | 2 | 2.62 | (0.32–9.45) |
20499 | 4 | 4.28 | (1.17–10.95) * | 1 | 5.92 | (0.15–32.99) | 2 | 3.16 | (0.38–11.41) | 1 | 10.63 | (0.27–59.24) |
21 | 5 | 3.27 | (1.06–7.62) * | 0 | 1 | 0.99 | (0.03–5.5) | 0 | ||||
22 | 9 | 1.40 | (0.64–2.65) | 2 | 0.96 | (0.12–3.45) | 5 | 1.15 | (0.37–2.69) | 1 | 0.83 | (0.02–4.61) |
22232 | 3 | 10.17 | (2.1–29.73) * | 0 | . | 2 | 9.96 | (1.21–35.99) * | 0 | . | ||
22259 | 2 | 5.60 | (0.68–20.22) | 0 | . | 2 | 8.24 | (1–29.76) * | 0 | |||
23 | 10 | 1.31 | (0.63–2.4) | 2 | 1.85 | (0.22–6.69) | 3 | 0.57 | (0.12–1.67) | 1 | 1.56 | (0.04–8.7) |
22234 | 0 | . | 1 | 25.43 | (0.64–141.71) | 0 | . | 1 | 41.94 | (1.06–233.66) * | ||
24 | 13 | 1.74 | (0.93–2.97) | 2 | 3.94 | (0.48–14.22) | 6 | 1.19 | (0.44–2.59) | 0 | ||
24211 | 1 | 3.29 | (0.08–18.32) | 1 | 39.87 | (1.01–222.12) * | 1 | 4.85 | (0.12–27.01) | 0 | ||
25 | 16 | 1.42 | (0.81–2.3) | 2 | 1.01 | (0.12–3.65) | 7 | 0.92 | (0.37–1.89) | 0 | ||
25119 | 4 | 3.78 | (1.03–9.67) * | 1 | 9.58 | (0.24–53.39) | 2 | 2.79 | (0.34–10.07) | 0 | ||
26 | 17 | 2.12 | (1.23–3.39) * | 8 | 2.07 | (0.89–4.08) | 5 | 0.97 | (0.32–2.27) | 3 | 1.54 | (0.32–4.5) |
28 | 7 | 1.43 | (0.57–2.94) | 2 | 1.27 | (0.15–4.59) | 4 | 1.22 | (0.33–3.12) | 1 | 1.13 | (0.03–6.31) |
28111 | 2 | 5.57 | (0.67–20.11) | 0 | . | 2 | 8.18 | (0.99–29.53) | 0 | |||
28902 | 1 | 40.88 | (1.04–227.79) * | 0 | . | 1 | 62.09 | (1.57–345.96) * | 0 | |||
29 | 18 | 1.86 | (1.1–2.95) * | 4 | 2.95 | (0.8–7.55) | 11 | 1.71 | (0.85–3.06) | 1 | 1.32 | (0.03–7.37) |
29199 | 1 | 0.64 | (0.02–3.58) | 2 | 8.61 | (1.04–31.12) * | 1 | 0.96 | (0.02–5.34) | 1 | 7.73 | (0.2–43.07) |
29141 | 6 | 9.17 | (3.37–19.96) * | 0 | . | 3 | 6.93 | (1.43–20.25) * | 0 | |||
29294 | 0 | . | 2 | 12.43 | (1.5–44.89) * | 0 | 0 | |||||
30 | 8 | 0.91 | (0.39–1.8) | 0 | 0 | (0–3) | 4 | 0.72 | (0.2–1.85) | 0 | ||
30331 | 1 | 68.84 | (1.74–383.58) * | 0 | . | 1 | 102 | (2.58–568.04) * | 0 | |||
31 | 7 | 1.59 | (0.64–3.28) | 1 | 2.87 | (0.07–15.97) | 2 | 0.68 | (0.08–2.47) | 1 | 5.07 | (0.13–28.25) |
3113 | 0 | . | 1 | 37.3 | (0.94–207.84) | 0 | . | 1 | 65.33 | (1.65–363.98) * |
KSIC | Men | Women | Men | Women | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
OBS | SIR | 95% CI | OBS | SIR | 95% CI | OBS | SMR | 95% CI | OBS | SMR | 95% CI | |
F | 76 | 1.72 | (1.37–2.15) * | 12 | 3.31 | (1.71–5.79) * | 43 | 1.40 | (1.04–1.89) * | 5 | 2.36 | (0.77–5.51) |
41 | 72 | 1.72 | (1.37–2.17) * | 12 | 3.54 | (1.83–6.18) * | 41 | 1.41 | (1.04–1.92) * | 5 | 2.54 | (0.82–5.92) |
411 | 25 | 1.63 | (1.1–2.41) * | 7 | 5.86 | (2.36–12.08) * | 21 | 1.97 | (1.28–3.02) * | 4 | 5.34 | (1.45–13.67) * |
41112 | 15 | 1.48 | (0.83–2.44) | 4 | 4.97 | (1.36–12.74) * | 14 | 1.99 | (1.09–3.34) * | 3 | 5.93 | (1.22–17.32) * |
41119 | 5 | 2.64 | (0.86–6.16) | 2 | 11.59 | (1.4–41.88) * | 2 | 1.51 | (0.18–5.46) | 1 | 9.24 | (0.23–51.48) |
41221 | 7 | 3.48 | (1.4–7.17) * | 0 | . | 4 | 2.86 | (0.78–7.31) | 0 | . | ||
41999 | 37 | 1.69 | (1.23–2.33) * | 5 | 2.70 | (0.88–6.3) | 15 | 0.99 | (0.55–1.63) | 1 | 1 | (0.03–5.55) |
412 | 10 | 2.17 | (1.04–3.99) * | 0 | 5 | 1.56 | (0.51–3.64) | 0 | ||||
419 | 37 | 1.69 | (1.23–2.33) * | 5 | 2.70 | (0.88–6.3) | 15 | 0.99 | (0.55–1.63) | 1 | 1 | (0.03–5.55) |
42 | 4 | 1.63 | (0.44–4.18) | 0 | 2 | 1.18 | (0.14–4.26) | 0 | ||||
422 | 3 | 6.61 | (1.36–19.33) * | 0 | 1 | 3.22 | (0.08–17.96) | 0 | ||||
42209 | 2 | 8.62 | (1.04–31.12) * | 0 | 0 | |||||||
G | 28 | 1.24 | (0.85–1.79) | 12 | 1.34 | (0.69–2.35) | 14 | 0.92 | (0.5–1.54) | 3 | 0.63 | (0.13–1.84) |
46 | 18 | 1.15 | (0.68–1.82) | 6 | 1.12 | (0.41–2.44) | 10 | 0.95 | (0.46–1.75) | 2 | 0.70 | (0.09–2.54) |
46201 | 0 | 0 | 0 | 1 | 46.57 | (1.18–259.44) * | ||||||
46432 | 0 | . | 1 | 75.33 | (1.91–419.73) * | 0 | . | 0 | . | |||
47 | 7 | 1.17 | (0.47–2.41) | 6 | 1.74 | (0.64–3.79) | 4 | 0.99 | (0.27–2.53) | 1 | 0.54 | (0.01–3.01) |
472 | 0 | 2 | 8.67 | (1.05–31.31) * | 0 | 0 | ||||||
47219 | 0 | . | 2 | 25.35 | (3.07–91.59) * | 0 | . | 0 | . | |||
47421 | 0 | . | 1 | 116.8 | (2.96–650.92) * | 0 | . | 0 | . | |||
H | 48 | 1.26 | (0.95–1.67) | 1 | 0.56 | (0.01–3.12) | 21 | 0.80 | (0.52–1.23) | 1 | 1 | (0.03–5.56) |
52 | 12 | 2.05 | (1.06–3.57) | 1 | 1.34 | (0.03–7.45) | 5 | 1.22 | (0.4–2.85) | 1 | 2.41 | (0.06–13.44) |
52104 | 1 | 30.89 | (0.78–172.11) | 0 | . | 1 | 45.01 | (1.14–250.78) * | 0 | |||
I | 11 | 2.10 | (1.05–3.75) * | 10 | 1.11 | (0.53–2.04) | 6 | 1.71 | (0.63–3.72) | 4 | 0.72 | (0.2–1.85) |
55 | 11 | 2.56 | (1.28–4.58) * | 10 | 1.35 | (0.65–2.48) | 6 | 2.07 | (0.76–4.51) | 4 | 0.91 | (0.25–2.33) |
551 | 7 | 4.03 | (1.62–8.3) * | 2 | 1.78 | (0.22–6.44) | 5 | 4.22 | (1.37–9.85) | 1 | 1.53 | (0.04–8.52) |
55101 | 5 | 3.45 | (1.12–8.06) * | 1 | 1.26 | (0.03–7.02) | 3 | 3.05 | (0.63–8.91) | 1 | 2.2 | (0.06–12.28) |
J | 14 | 1.70 | (0.93–2.85) | 4 | 1.84 | (0.5–4.71) | 7 | 1.29 | (0.52–2.65) | 2 | 1.86 | (0.23–6.71) |
59 | 1 | 2.51 | (0.06–13.98) | 0 | 1 | 3.74 | (0.09–20.82) | 0 | ||||
592 | 1 | 57.81 | (1.46–322.09) * | 0 | 1 | 89.08 | (2.26–496.31) * | 0 | ||||
59201 | 1 | 71.31 | (1.81–397.3) * | 0 | . | 1 | 108.8 | (2.75–606.1) * | 0 | . | ||
63 | 2 | 3.91 | (0.47–14.14) | 2 | 6.45 | (0.78–23.28) | 1 | 2.85 | (0.07–15.9) | 1 | 6.25 | (0.16–34.84) |
63999 | 2 | 6.13 | (0.74–22.13) | 2 | 9.92 | (1.2–35.83) * | 1 | 4.36 | (0.11–24.29) | 1 | 9.25 | (0.23–51.53) |
L | 39 | 1.34 | (0.98–1.83) | 7 | 1.95 | (0.78–4.02) | 13 | 0.60 | (0.32–1.03) | 3 | 1.26 | (0.26–3.68) |
68211 | 31 | 1.4 | (0.99–2) | 3 | 1.70 | (0.35–4.97) | 10 | 0.60 | (0.29–1.11) | 2 | 1.66 | (0.2–6) |
O | 9 | 1.02 | (0.47–1.94) | 3 | 0.67 | (0.14–1.95) | 5 | 0.74 | (0.24–1.73) | 1 | 0.32 | (0.01–1.81) |
84 | 9 | 1.02 | (0.47–1.94) | 3 | 0.67 | (0.14–1.95) | 5 | 0.74 | (0.24–1.73) | 1 | 0.32 | (0.01–1.81) |
842 | 2 | 1.53 | (0.18–5.51) | 3 | 6.31 | (1.3–18.44) * | 0 | 1 | 3.43 | (0.09–19.09) | ||
84221 | 0 | . | 1 | 59.51 | (1.51–331.58) * | 0 | 0 | |||||
R | 1 | 0.66 | (0.02–3.69) | 1 | 1.74 | (0.04–9.67) | ||||||
90 | 0 | 1 | 8.07 | (0.2–44.94) | 0 | |||||||
90221 | 0 | . | 1 | 68.76 | (1.74–383.12) * | 0 | 0 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kim, E.-A. Standardized Incidence Ratio and Standardized Mortality Ratio of Malignant Mesothelioma in a Worker Cohort Using Employment Insurance Database in Korea. Int. J. Environ. Res. Public Health 2021, 18, 10682. https://doi.org/10.3390/ijerph182010682
Kim E-A. Standardized Incidence Ratio and Standardized Mortality Ratio of Malignant Mesothelioma in a Worker Cohort Using Employment Insurance Database in Korea. International Journal of Environmental Research and Public Health. 2021; 18(20):10682. https://doi.org/10.3390/ijerph182010682
Chicago/Turabian StyleKim, Eun-A. 2021. "Standardized Incidence Ratio and Standardized Mortality Ratio of Malignant Mesothelioma in a Worker Cohort Using Employment Insurance Database in Korea" International Journal of Environmental Research and Public Health 18, no. 20: 10682. https://doi.org/10.3390/ijerph182010682